Pharma R&D: Taking the digital route

With the integrated predictive analytics available today, health-specific data can be used for generating invaluable clinical insights to tackle various disease burdens with novel strategic approaches.

- Arno Tellmann

Drug development is considered one of the most critical engines that drive the growth story of the pharmaceutical industry. Penetration and adoption of emerging technologies, like artificial intelligence and machine learning combined with data-reliant predictive analyses, is expected to transform pharmaceutical R&D, operational models.

Digital revolution: Pacing it up

The global pharmaceutical industry has been shoring up its R&D capabilities through the steady inflow of investments and resource developments, especially in emerging markets in the Asia Pacific region. In fact in India, Novartis has a digital hub called Biome India, which is aimed at establishing a network between Novartis and external partners from across the digital ecosystem. This is the first such hub in Asia and owing to India’s technological capabilities, offers great opportunities to provide patients with digital-led solutions. Clearly, there is a digital revolution on the horizon and countries are keenly embracing it to stay ahead of the curve.

Digital in Pharma R&D